Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Surgery Partners (SGRY) Shares Outstanding (Weighted Average) (2016 - 2025)

Surgery Partners (SGRY) has disclosed Shares Outstanding (Weighted Average) for 13 consecutive years, with $127.2 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 0.86% to $127.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $127.2 million through Dec 2025, up 0.86% year-over-year, with the annual reading at $127.2 million for FY2025, 0.86% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $127.2 million in Q4 2025 for Surgery Partners, roughly flat from $126.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $127.2 million in Q4 2025 to a low of $54.8 million in Q1 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $107.1 million across 5 years, with a median of $125.6 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): surged 65.64% in 2021 and later increased 0.33% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $72.4 million in 2021, then rose by 26.96% to $92.0 million in 2022, then skyrocketed by 36.61% to $125.6 million in 2023, then grew by 0.41% to $126.1 million in 2024, then rose by 0.86% to $127.2 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for SGRY at $127.2 million in Q4 2025, $126.9 million in Q3 2025, and $126.8 million in Q2 2025.